AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Your donation will support the student journalists of the Iowa State Daily. Your contribution will allow us to purchase equipment, send our student journalists to conferences and off-set their cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback